PharmiWeb.com - Global Pharma News & Resources
21-Sep-2022

Baxter International Inc. (NYSE:BAX) Company Profile Report [+Annual Revenue USD 12,784 Mn] – Market.us

Pune, Maharashtra, India, September 21 2022 (Wiredrelease) Prudour Pvt. Ltd –:Introduction: Baxter International Inc.

Baxter International Inc. is a global medical products and services company with operations in more than 100 countries. The company develops, manufactures and markets a broad range of medical products, including intravenous (IV) solutions and nutrition products, dialysis equipment, drugs and blood-testing supplies. Baxter’s product line includes more than 5,000 items, ranging from simple IV solutions to complex biologic drugs. The company also provides a variety of services, such as renal dialysis, pharmacy compounding and blood-testing laboratories.

Company History

Baxter International Inc. is a Fortune 500 global medical products and services company with more than 100,000 employees worldwide. The company operates in more than 50 countries and serves patients and clinicians in over 100 nations.

Baxter was founded in 1931 by Donald Baxter, a young medical doctor who developed a new way to treat blood loss that saved the lives of countless soldiers during World War II. After the war, Baxter began developing other life-saving innovations such as the first disposable surgical glove and the first intravenous (IV) solution. Today, Baxter continues to develop new products and technologies to save and improve lives around the world.

Financials

Revenue (US$ Mn):

Baxter International Inc.’s annual revenue for 2021 was US$ 12,784 Mn, a 9.52% increase from 2020

The annual revenue generated by Baxter International Inc. in 2020 was US$ 11,673 Mn

At a 2.11% increase, Baxter International Inc.’s annual revenue of US$ 11,362 Mn was indexed in 2019

Baxter International Inc. generated total revenue of US$ 11,127 Mn in 2018

You can directly purchase using this secure link: https://market.us/purchase-company/?company_id=84004

Operating Income (US$ Mn):

US$ 1,710 Mn was the operating income generated by Baxter International Inc. in 2021

Baxter International Inc.’s operating income for 2020 was US$ 1,616 Mn, a -8.8% decrease from 2019

From 2018’s operating incomes, Baxter International Inc. registered a 10.82% increase in 2019, amounting to US$ 1,772 Mn

An operating income of US$ 1,599 Mn was generated in 2018 by Baxter International Inc.

Gross Margin %:

40% was the gross margin generated by Baxter International Inc. in 2021

Baxter International Inc.’s gross margin for 2020 was 39%, a -6.44% decrease from 2019

From 2018’s gross margins, Baxter International Inc. registered a -2.56% decrease in 2019, amounting to 42%

A gross margin of 43% was generated in 2018 by Baxter International Inc.

Access full Company Profile Description@ https://market.us/company/baxter-international-inc/

Recent developments

Baxter International Inc. has seen some recent developments that may be of interest to investors. The company announced that it would be selling its Renal business to Fresenius Medical Care for $4 billion. This move will help Baxter focus on its core businesses and should result in a more efficient company. In addition, Baxter has been working on expanding its product portfolio with the acquisition of Chemetall, a German chemical company. This will give Baxter a wider range of products to offer its customers and should help boost sales.

This content has been published by Prudour Pvt. Ltd company. The WiredRelease News Department was not involved in the creation of this content. For press release service enquiry, please reach us at contact@wiredrelease.com.

Editor Details

Last Updated: 21-Sep-2022